Replies to post #210004 on Biotech Values

[mr_o]

Will this lead to a daytime television lawsuit commercial?

[DewDiligence]

ABT withdraws ABSORB stent from EU market (with limited exceptions):

http://epvantage.com/Universal/View.aspx?type=Story&id=699747&isEPVantage=yes

This is a rare commercial setback for ABT, who invested a lot in the development of ABSORB and the bioabsorbable-stent technology on which it is based. Although ABSORB is still on the market in the US, the sales are apt to be small following the data reported in #msg-129683267.

ABT is trading flat today.